|
Data of patients and clinical characteristics (n = 122) |
||
| Median |
Range |
|
|
|
||
| Age, years |
1.4 |
0.16–22 |
| Weight, kg |
8 |
2.5–85 |
|
|
||
| Diagnoses |
Number |
Percentage |
|
|
||
| Cardiac surgery |
54 |
44.2 |
| Sepsis |
22 |
18 |
| Nephropaties |
15 |
12.2 |
| Oncologic diseases |
10 |
8.2 |
| Cardiopathies |
8 |
6.5 |
| Gastrointestinal surgery |
3 |
2.4 |
| Hemolytic-uremic syndrome |
3 |
2.4 |
| Metabolic diseases |
3 |
2.4 |
| Others |
4 |
3.2 |
|
|
||
| CRRT indication |
||
|
|
||
| Acute renal failure |
51 |
42 |
| Fluid overload |
22 |
18 |
| Acute renal failure plus fluid overload |
39 |
32 |
| Tumor lysis |
5 |
4 |
| Others |
5 |
4 |
|
|
||
| Median |
Range |
|
|
|
||
| Initial creatinine, mg/dL |
2.4 |
0.1–7.8 |
| Creatinine after 24 hours of CRRT, mg/dL |
1.5 |
0.1–3.9 |
| Initial urea, mg/dL |
104 |
6–290 |
| Urea after 24 hours of CRRT, mg/dL |
67.2 |
11–199 |
|
|
||
| Number |
Percentage |
|
|
|
||
| Mechanical ventilation |
98 |
84.5 |
| Inotropic drug support |
89 |
73 |
|
|
||
| Mean |
Standard deviation |
|
|
|
||
| PRISM score at the beginning of CRRT |
14 |
8.3 |
| PELOD score at the beginning of CRRT |
14.6 |
8.0 |
| Number of failed organs |
3 |
72% >2 organs |
|
|
||
| Number |
Percentage |
|
|
|
||
| Survival |
84 |
68.9 |
|
CRRT, continuous renal replacement therapy; PELOD, pediatric logistic organ dysfunction; PRISM, pediatric risk of mortality. | ||
del Castillo et al. Critical Care 2008 12:R93 doi:10.1186/cc6965 |
||